US Patent 10508151 Anti-transferrin receptor antibodies and methods of use
Patent 10508151 was granted and assigned to Genentech on December, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+110 characters)
Article
Patent abstract
The present invention relates to anti-transferrin receptor antibodies and methods of their use.
Edits on 3 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Gregory A Lazar0
James A Ernst0
Jasvinder Atwal0
Jessica Couch0
Joy Yu Zuchero0
Mark S Dennis0
Ryan J Watts0
Yin Zhang0
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105081510
Date of Patent
December 17, 2019
0Patent Application Number
155258320
Date Filed
November 18, 2015
0Patent Citations Received
Patent Primary Examiner
Golden AI
Infobox
Patent Citations Received
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 7 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 31 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10508151 Anti-transferrin receptor antibodies and methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10508151
Date of patent
December 17, 2019
Patent application number
15525832
Date Filed
November 18, 2015
Patent primary examiner
Find more entities like US Patent 10508151 Anti-transferrin receptor antibodies and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
